An Update on Randomized Clinical Trials in Melanoma

Area of Science:

• Oncology
• Clinical Trials
• Dermatology

Background:

• Melanoma remains a significant health concern despite treatment advancements.
• Numerous randomized trials have been conducted to optimize melanoma management.
• Research efforts span from 1975 to the present, addressing various stages of the disease.

Purpose of the Study:

• To review practice-changing randomized trials in melanoma treatment.
• To synthesize findings on local, regional, and metastatic melanoma management.
• To highlight advancements in surgical and adjuvant therapies.

Main Methods:

• Systematic review of prospective randomized trials in melanoma.
• Analysis of trials conducted between 1975 and 2000.
• Inclusion of recent trials (2001-present) focusing on surgery and metastatic disease.

Main Results:

• Over 154 randomized trials were identified from 1975-2000.
• Recent trials have refined the roles of surgery and adjuvant treatments.
• Evidence-based strategies for metastatic melanoma have been established.

Conclusions:

• Randomized trials have significantly improved melanoma treatment protocols.
• Ongoing research continues to refine therapeutic approaches.
• This review consolidates key findings for clinical practice.